标题
PCSK9: A novel inflammation modulator in atherosclerosis?
作者
关键词
-
出版物
JOURNAL OF CELLULAR PHYSIOLOGY
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2018-09-24
DOI
10.1002/jcp.27254
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- PCSK9 plays a novel immunological role in oxidized LDL-induced dendritic cell maturation and activation of T cells from human blood and atherosclerotic plaque
- (2018) A. Liu et al. JOURNAL OF INTERNAL MEDICINE
- PCSK9 induces a pro-inflammatory response in macrophages
- (2018) Chiara Ricci et al. Scientific Reports
- PCSK9 monoclonal antibodies reverse the pro-inflammatory profile of monocytes in familial hypercholesterolaemia
- (2017) Sophie J. Bernelot Moens et al. EUROPEAN HEART JOURNAL
- The AT04A vaccine against proprotein convertase subtilisin/kexin type 9 reduces total cholesterol, vascular inflammation, and atherosclerosis in APOE*3Leiden.CETP mice
- (2017) Christine Landlinger et al. EUROPEAN HEART JOURNAL
- PCSK9 in chronic kidney disease
- (2017) P. Pavlakou et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- PCSK9 and Atherosclerosis - Lipids and Beyond
- (2017) Michael D. Shapiro et al. Journal of Atherosclerosis and Thrombosis
- PCSK9 at the crossroad of cholesterol metabolism and immune function during infections
- (2017) Francesco Paciullo et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Investigation of highly expressed PCSK9 in atherosclerotic plaques and ox-LDL-induced endothelial cell apoptosis
- (2017) Jiao Li et al. Molecular Medicine Reports
- Atherosclerosis: PCSK9 inhibition reduces cardiovascular events in high-risk patients
- (2017) Karina Huynh Nature Reviews Cardiology
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
- (2017) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Linking resistin, inflammation, and cardiometabolic diseases
- (2017) Hyeong Kyu Park et al. KOREAN JOURNAL OF INTERNAL MEDICINE
- Cross-Talk Between PCSK9 and Damaged mtDNA in Vascular Smooth Muscle Cells: Role in Apoptosis
- (2016) Zufeng Ding et al. ANTIOXIDANTS & REDOX SIGNALING
- Inflammation in atherosclerosis
- (2016) Soraya Taleb Archives of Cardiovascular Diseases
- PCSK9 and atherosclerosis: Beyond LDL-cholesterol lowering
- (2016) Bertrand Cariou et al. ATHEROSCLEROSIS
- PCSK9 in relation to coronary plaque inflammation: Results of the ATHEROREMO-IVUS study
- (2016) Jin M. Cheng et al. ATHEROSCLEROSIS
- Human PCSK9 promotes hepatic lipogenesis and atherosclerosis development via apoE- and LDLR-mediated mechanisms
- (2016) Hagai Tavori et al. CARDIOVASCULAR RESEARCH
- Biology of proprotein convertase subtilisin kexin 9: beyond low-density lipoprotein cholesterol lowering
- (2016) Giuseppe Danilo Norata et al. CARDIOVASCULAR RESEARCH
- LOX-1-Mediated Effects on Vascular Cells in Atherosclerosis
- (2016) Dimitry A. Chistiakov et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Circulating Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Predicts Future Risk of Cardiovascular Events Independently of Established Risk FactorsCLINICAL PERSPECTIVE
- (2016) Karin Leander et al. CIRCULATION
- The role of mitochondrial DNA damage in the development of atherosclerosis
- (2016) Emma P.K. Yu et al. FREE RADICAL BIOLOGY AND MEDICINE
- Association between plasma PCSK9 levels and 10-year progression of carotid atherosclerosis beyond LDL-C: A cohort study
- (2016) Wuxiang Xie et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- A review of PCSK9 inhibition and its effects beyond LDL receptors
- (2016) Dave L. Dixon et al. Journal of Clinical Lipidology
- Increased Plasma PCSK9 Levels Are Associated with Reduced Endotoxin Clearance and the Development of Acute Organ Failures during Sepsis
- (2016) John H. Boyd et al. Journal of Innate Immunity
- Both STAT3 activation and cholesterol efflux contribute to the anti-inflammatory effect of apoA-I/ABCA1 interaction in macrophages
- (2016) Chongren Tang et al. JOURNAL OF LIPID RESEARCH
- LRP1 modulates the microglial immune response via regulation of JNK and NF-κB signaling pathways
- (2016) Longyu Yang et al. Journal of Neuroinflammation
- Targeting PCSK9 as a promising new mechanism for lowering low-density lipoprotein cholesterol
- (2016) Laura A. Della Badia et al. PHARMACOLOGY & THERAPEUTICS
- LDL receptor-related protein-1 regulates NFκB and microRNA-155 in macrophages to control the inflammatory response
- (2016) Elisabetta Mantuano et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Differential Expression of PCSK9 Modulates Infection, Inflammation, and Coagulation in a Murine Model of Sepsis
- (2016) Dhruva J. Dwivedi et al. SHOCK
- Vascular smooth muscle cell in atherosclerosis
- (2015) D. A. Chistiakov et al. Acta Physiologica
- The Central Role of Proprotein Convertase Subtilisin/Kexin Type 9 in Septic Pathogen Lipid Transport and Clearance
- (2015) Keith R. Walley et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Hemodynamic Shear Stress via ROS Modulates PCSK9 Expression in Human Vascular Endothelial and Smooth Muscle Cells and Along the Mouse Aorta
- (2015) Zufeng Ding et al. ANTIOXIDANTS & REDOX SIGNALING
- The association of resistin with cardiovascular disease in the Multi-Ethnic Study of Atherosclerosis
- (2015) Evan D. Muse et al. ATHEROSCLEROSIS
- Cross-talk between LOX-1 and PCSK9 in vascular tissues
- (2015) Zufeng Ding et al. CARDIOVASCULAR RESEARCH
- Role of PCSK9 beyond liver involvement
- (2015) Bertrand Cariou et al. CURRENT OPINION IN LIPIDOLOGY
- Prognostic value of PCSK9 levels in patients with acute coronary syndromes
- (2015) Baris Gencer et al. EUROPEAN HEART JOURNAL
- Efficacy and safety of alirocumab in high cardiovascular risk patients with inadequately controlled hypercholesterolaemia on maximally tolerated doses of statins: the ODYSSEY COMBO II randomized controlled trial
- (2015) Christopher P. Cannon et al. EUROPEAN HEART JOURNAL
- PCSK9: A key factor modulating atherosclerosis
- (2015) Sha Li et al. Journal of Atherosclerosis and Thrombosis
- Suppressor of Cytokine Signaling-3 (SOCS-3) Induces Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Expression in Hepatic HepG2 Cell Line
- (2015) Massimiliano Ruscica et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Local effects of human PCSK9 on the atherosclerotic lesion
- (2015) Ilaria Giunzioni et al. JOURNAL OF PATHOLOGY
- National prevalence of coronary heart disease and its relationship with human development index: A systematic review
- (2015) Ke-Fu Zhu et al. European Journal of Preventive Cardiology
- Relation of resistin to proprotein convertase subtilisin–kexin type 9 levels in coronary artery disease patients with different nutritional status
- (2015) S. Li et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Association of plasma PCSK9 levels with white blood cell count and its subsets in patients with stable coronary artery disease
- (2014) Sha Li et al. ATHEROSCLEROSIS
- Role of vascular smooth muscle cell in the inflammation of atherosclerosis
- (2014) Soyeon Lim et al. BMB Reports
- LOX-1, oxidant stress, mtDNA damage, autophagy, and immune response in atherosclerosis
- (2014) Zufeng Ding et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- PCSK9
- (2014) Nabil G. Seidah et al. CIRCULATION RESEARCH
- Resistin: An Inflammatory Cytokine. Role in Cardiovascular Diseases, Diabetes and the Metabolic Syndrome
- (2014) Nicola Abate et al. CURRENT PHARMACEUTICAL DESIGN
- LOX-1 and ROS, inseparable factors in the process of endothelial damage
- (2014) V. Lubrano et al. FREE RADICAL RESEARCH
- Shear-sensitive microRNA-34a modulates flow-dependent regulation of endothelial inflammation
- (2014) W. Fan et al. JOURNAL OF CELL SCIENCE
- Relation of circulating PCSK9 concentration to fibrinogen in patients with stable coronary artery disease
- (2014) Yan Zhang et al. Journal of Clinical Lipidology
- Alirocumab inhibits atherosclerosis, improves the plaque morphology, and enhances the effects of a statin
- (2014) Susan Kühnast et al. JOURNAL OF LIPID RESEARCH
- Shear Stress and Atherosclerosis
- (2014) Kyung-Sun Heo et al. MOLECULES AND CELLS
- PCSK9 is a critical regulator of the innate immune response and septic shock outcome
- (2014) K. R. Walley et al. Science Translational Medicine
- Mitochondrial DNA damage and atherosclerosis
- (2014) Emma P.K. Yu et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- PCSK9 plays a significant role in cholesterol homeostasis and lipid transport in intestinal epithelial cells
- (2013) Emile Levy et al. ATHEROSCLEROSIS
- Low density receptor-related protein 1 (LRP1) promotes anti-inflammatory phenotype in murine macrophages
- (2013) Petra May et al. CELL AND TISSUE RESEARCH
- Inflammation and Atherosclerosis—Revisited
- (2013) Sadip Pant et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- The influence of factors on dewaterability of one-stage autothermal thermophilic aerobically digested sludges
- (2013) Jiehong Cheng et al. WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY
- Fibrinogen facilitates atherosclerotic formation in Sprague-Dawley rats: A rodent model of atherosclerosis
- (2013) BIRONG ZHOU et al. Experimental and Therapeutic Medicine
- Inflammation in Atherosclerosis
- (2012) Peter Libby ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- White blood cell count is associated with carotid and femoral atherosclerosis
- (2012) Emilio Ortega et al. ATHEROSCLEROSIS
- The Biological Role of Inflammation in Atherosclerosis
- (2012) Brian W. Wong et al. CANADIAN JOURNAL OF CARDIOLOGY
- Smooth muscle cell phenotypic switching in atherosclerosis
- (2012) D. Gomez et al. CARDIOVASCULAR RESEARCH
- LOX-1 in atherosclerosis: biological functions and pharmacological modifiers
- (2012) Suowen Xu et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Gene Inactivation of Proprotein Convertase Subtilisin/Kexin Type 9 Reduces Atherosclerosis in Mice
- (2012) Maxime Denis et al. CIRCULATION
- PCSK9 siRNA suppresses the inflammatory response induced by oxLDL through inhibition of NF-κB activation in THP-1-derived macrophages
- (2012) ZHIHAN TANG et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Celastrol attenuates adipokine resistin-associated matrix interaction and migration of vascular smooth muscle cells
- (2012) Sang-Wook Kang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Discovery of a New Role of Human Resistin in Hepatocyte Low-Density Lipoprotein Receptor Suppression Mediated in Part by Proprotein Convertase Subtilisin/Kexin Type 9
- (2012) Michelle Melone et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effect of Porphyromonas gingivalis infection on post-transcriptional regulation of the low-density lipoprotein receptor in mice
- (2012) Haruna Miyazawa et al. Lipids in Health and Disease
- White Blood Cell Count and the Risk for Coronary Artery Disease in Young Adults
- (2012) Gilad Twig et al. PLoS One
- Apolipoprotein E Induces Antiinflammatory Phenotype in Macrophages
- (2011) Daniel Baitsch et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Monocyte and Macrophage Dynamics During Atherogenesis
- (2011) Klaus Ley et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Proprotein convertase subtilisin kexin type 9 (PCSK9) secreted by cultured smooth muscle cells reduces macrophages LDLR levels
- (2011) Nicola Ferri et al. ATHEROSCLEROSIS
- Resistin: functional roles and therapeutic considerations for cardiovascular disease
- (2011) Md S Jamaluddin et al. BRITISH JOURNAL OF PHARMACOLOGY
- Human Vascular Endothelial Cells: A Model System for Studying Vascular Inflammation in Diabetes and Atherosclerosis
- (2011) Duygu Onat et al. Current Diabetes Reports
- Unexpected roles for PCSK9 in lipid metabolism
- (2011) Anne K Soutar CURRENT OPINION IN LIPIDOLOGY
- PCSK9 siRNA inhibits HUVEC apoptosis induced by ox-LDL via Bcl/Bax–caspase9–caspase3 pathway
- (2011) Chun-Yan Wu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- A Prospective Natural-History Study of Coronary Atherosclerosis
- (2011) Gregg W. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fibrinogen as a key regulator of inflammation in disease
- (2011) Dimitrios Davalos et al. Seminars in Immunopathology
- Flow Shear Stress and Atherosclerosis: A Matter of Site Specificity
- (2010) Patrizia Nigro et al. ANTIOXIDANTS & REDOX SIGNALING
- Role of hemodynamic shear stress in cardiovascular disease
- (2010) Emanuele Cecchi et al. ATHEROSCLEROSIS
- Immune and Inflammatory Mechanisms of Atherosclerosis
- (2009) Elena Galkina et al. Annual Review of Immunology
- PCSK9 is expressed in pancreatic δ-cells and does not alter insulin secretion
- (2009) Cédric Langhi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The role of resistin as a regulator of inflammation: Implications for various human pathologies
- (2009) Mária Filková et al. CLINICAL IMMUNOLOGY
- Growing Epidemic of Coronary Heart Disease in Low- and Middle-Income Countries
- (2009) Thomas A. Gaziano et al. CURRENT PROBLEMS IN CARDIOLOGY
- The Macrophage Cholesterol Exporter ABCA1 Functions as an Anti-inflammatory Receptor
- (2009) Chongren Tang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Resistin competes with lipopolysaccharide for binding to toll-like receptor 4
- (2009) Andrej Tarkowski et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- The connection between C‐reactive protein and atherosclerosis
- (2008) Sanjay K. Singh et al. ANNALS OF MEDICINE
- Inflammation stimulates the expression of PCSK9
- (2008) Kenneth R. Feingold et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Increased Cellular Free Cholesterol in Macrophage-specificAbca1Knock-out Mice Enhances Pro-inflammatory Response of Macrophages
- (2008) Xuewei Zhu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More